Secondary stroke prevention in the elderly: New evidence in hypertension and hyperlipidemia

European Journal of Internal Medicine

Volumn 20, Issue 6, 2009, Pages 586-590

  Castilla Guerra, Luis ^a   Fernández Moreno, María del Carmen ^b   Álvarez Suero, Jesus ^a  

^a HOSPITAL DE LA MERCED   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Elderly patients; Hypertension; Lipids; Secondary prevention; Stroke

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERINDOPRIL; PLACEBO; TRIACYLGLYCEROL;

AGE; AGED; CHOLESTEROL BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MYALGIA; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SIDE EFFECT; STROKE; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; RECURRENCE; SECONDARY PREVENTION; STROKE;

EID: 70349431121     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.06.005     Document Type: Review

References (43)

1. WHO. Active ageing: a policy framework (2002), World Health Organization, Geneva
2. Wolf P.A., D'Agostino R.B., O'Neal M.A., Sytkowski P., Kase C.S., Belanger A.J., et al. Secular trend in stroke incidence and mortality: the Framinghan study. Stroke 23 (1992) 1551-1555
3. van Wijk I., Kappelle L.J., van Gijn J., Koudstaal P.J., Franke C.L., Vermeulen M., et al., LiLAC Study Group. Long-term survival and vascular event risk after transient ischemic attack or minor ischemic stroke: a cohort study. Lancet 365 (2005) 2098-2104
4. Johnston S.C., Gress D.R., Browner W.S., and Sidney S. Short-term prognosis after emergency diagnosis of TIA. JAMA 284 (2000) 2901-2906
5. Islam M.S., Anderson C.S., Hankey G.J., Hardie K., Carter K., Broadhurst R., et al. Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study. Stroke 39 (2008) 776-782
6. Rautio A., Eliasson M., and Stegmayr B. Favorable trends in the incidence and outcome in stroke in nondiabetic and diabetic subjects: findings from the Northern Sweden MONICA Stroke Registry in 1985 to 2003. Stroke 39 (2008) 3137-3144
7. Robinson J.G., Bakris G., Torner J., Stone N.J., and Wallance R. Is it time for a cardiovascular primary prevention trial in the elderly?. Stroke 38 (2007) 441-450
8. Kaplan R.C., Tirschwell D.L., Longstreth Jr. W.T., Manolio T.A., Heckbert S.R., Lefkowitz D., et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology 65 (2005) 835-842
9. Zhang H., Thijs L., and Staessen J.A. Blood pressure for primary and secondary prevention of stroke. Hypertension 48 (2006) 187-195
10. Aronow W.S. Treatment of hypertension in the elderly. Geriatrics 63 (2008) 21-25
11. Williams M.A., Fleg J.L., Ades P.A., Chaitman B.R., Miller N.H., Mohiuddin S.M., et al. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients ≥75 years of age): an American Heart Association scientific statement from the council on clinical cardiology subcommittee on exercise, cardiac rehabilitation, and prevention. Circulation 105 (2002) 1735-1743
12. Rigaud A.S., and Forette B. Hypertension in older adults. J Gerontol 56 (2001) 217-225
13. Chaundhry S.I., Krumholz H.M., and Foody J.M. Systolic hypertension in older persons. JAMA 292 (2004) 1074-1080
14. Prospective Study Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346 (1995) 1647-1653
15. Prospective Study Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
16. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ 336 (2008) 1121-1123
17. Gueyffier F., Bulpitt C., Boissel J.P., Schron E., Ekbom T., Fagard R., et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. INDANA Group. Lancet 353 (1999) 793-796
18. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee l. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
19. Mansia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al., European Society of Hypertension; European Society of Cardiology. 007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC. Blood Press 16 3 (2007) 135-232
20. Beckett N.S., Peters R., Fletcher A.E., Staessen J.A., Liu L., Dumitrascu D., et al., HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008) 1887-1898
21. Kostis J.B. Treating hypertension in the very old. N Eng J Med 358 (2008) 1958-1960
22. Staessen J.A., Fagard R., Thijs L., Celis H., Arabidze G.G., Birkenhäger W.H., et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350 (1997) 757-764
23. Fagard R.H. Does low on-treatment diastolic blood pressure influence prognosis in systolic hypertension patients?. Cardiovasc Rev 25 25 (2008) 28-31
24. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al., American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
25. PATS Collaborating Group. Post-stroke Antihypertensive Treatment Study. Chin Med J 108 (1995) 710-717
26. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
27. Schrader J., Lüders S., Kulschewski A., Hammersen F., Plate K., Berger J., et al., MOSES Study Group. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES. Stroke 36 (2005) 121-126
28. Aronow W.S. Managing hyperlipidaemia in the elderly. Special considerations for a population at high risk. Drugs Aging 23 (2006) 181-189
29. Castilla Guerra L., Fernández Moreno M.C., López Chozas J.M., and Jiménez Hernández M.D. Statins in stroke prevention: what an internist should know. Eur J Intern Med 19 (2008) 8-14
30. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 vascular deaths. Lancet 370 (2007) 1829-1839
31. Katzel L.I., and Golberg A.P. Dyslipoproteinemia. 5th ed. In: Hazzard W.R. (Ed) (2003), McGraw-Hill Professional, New York, NY 875-879
32. Ali R., and Alexander K.P. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Am J Geriatr Pharmacol 5 (2007) 52-63
33. Walker D.B., and Jacobson T.A. Initiating statins in the elderly: the evolving challenge. Curr Opin Endocrinol Diabetes Obes 15 (2008) 182-187
34. Miettienen T.A., Pyörälä K., Olsson A.G., Musliner T.A., Cook T.J., Faergeman O., et al., Scandinavian Simavastatin Survival Study Group. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandianvian Simvastatin Survival Study (4S. Circulation 96 (1997) 4211-4218
35. Lewis S.J., Moye L.A., Sacks F.M., Johnstone D.E., Timmis G., Mitchell J., et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 129 (1998) 681-689
36. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., et al., PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
37. Cholesterol Treatment Trialists'(CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 366 (2005) 1267-1278
38. Afilalo J., Duque G., Steele R., Jukema J.W., de Craen A.J.M., and Eisenberg M.J. Statins for secondary prevention in elderly patients. A hierarchical Bayesian meta-analysis. J Am Coll Cardiol 51 (2008) 37-45
39. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals. A randomised placebo-control trial. Lancet 360 (2002) 7-22
40. Amarenco P., Labreuche J., Lavallée P.H., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis. Stroke 35 (2004) 2902-2909
41. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
42. Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, Goldstein LB, et al. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. 2008 September 3. (Published ahead of print)
43. Castilla-Guerra L., Fernandez-Moreno M.C., and Jiménez-Hernández M.D. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack [electronic response to Chaturvedi S et al]. Neurology (2009). http://www.neurology.org/cgi/eletters/01.wnl.0000327339.55844.1av1#38127 http://www.neurology.org/cgi/eletters/01.wnl.0000327339.55844.1av1#38127